HARVARD BIOSCIENCE INC (HBIO) › Operating Cash FlowHARVARD BIOSCIENCE INC (HBIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: $16.51M2010: $12.29M2011: $6.65M2012: $8.06M2013: $4.06M2014: $4.35M2015: $705.0K2016: $5.38M2017: $1.06M2018: $2.88M2019: $8.04M2020: $9.33M2021: $1.26M2022: $1.15M2023: $14.03M2024: $1.44M2025: $6.73M$6.73M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$6.73M+367.3%2024$1.44M-89.7%2023$14.03M+1117.7%2022$1.15M-8.7%2021$1.26M-86.5%2020$9.33M+16.0%2019$8.04M+179.0%2018$2.88M+172.8%2017$1.06M-80.4%2016$5.38M+663.5%2015$705.0K-83.8%2014$4.35M+7.2%2013$4.06M-49.6%2012$8.06M+21.3%2011$6.65M-45.9%2010$12.29M-25.5%2009$16.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share